Home
About Us
A new report from the European Central Bank is out, and it calls for price controls on prescription drugs to cut down on drug costs and spur innovation, the Wall Street Journal reports.
The report's author, Mario Draghi, says price controls could reduce drug prices by 30% to 50% over the next five years, according to a press release.
But the Journal notes that the report " stops short of exploring more deeply the impact of price regulation on future drug innovation.
This raises questions about the consequences of restrictive policies like price controls, which can undermine innovation by reducing the financial incentives for private R&D investment, and can have global implications a point that Draghi's report does not fully explore."
The report also calls for more public and private investment in drug research.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Creative Australia has announced the appointment of Leisa Bacon as its new Executive Director, Development and Partnerships.Bacon brings over 20 years of executive leadership experience in major...more
There is an estimated global climate investment gap of USD 6.1 trillion per year by 2030.Annual climate investments must increase fivefold to keep global temperature rises within 1.5 C by the end of...more
Daring Capital is an impact investing syndicate.Its mission is to invest in underrepresented founders building for-profit companies.These include individuals facing poverty, discrimination, or lack...more
The cultural festival organised by NAFEST had the various troupes in the country in participation, with the team from Anambra, in an amazing performance and cultural skills, emerging the most...more
The impact of climate change could drive fixed-asset losses of $560-610 billion per year across listed companies by 2035.The report aims to help business leaders recognise that the longevity of...more
In part one of a three-part article, Rick Heath examines why the Australian arts industry is not valued or invested in appropriately.The potential outcomes are so huge, says Heath.Has arts investment...more
Foundation: Venture Philanthropy Partners
Community-based organizations are one of the greatest levers for change, says Gretchen Van der Veer, CEO of Fair Chance.Funders can play a critical role by making strategic investments in nonprofits,...more
Wharton and SP2 Receive $5 million for the Wieler Family Professorship on Social Impact and Philanthropy.It is the first-ever professorship in philanthropy for a faculty member with appointments in...more
'New Realities, New Opportunities': AVPN South Asia Summit 2024 Announces Major Cross-Sector Initiatives.AVPN is the largest network of social investors in Asia.The Summit focuses on addressing South...more
'Impact investing is not just for returns, diversification but also risk reduction,' says LeapFrog CEO.Impact investing is emerging as a lower-risk alternative to traditional private equity,...more
Social Innovation News from...
Changemakers
Boeing Company
Social Entrepreneurship
Spotlight
Keeping Half the Profits Beats Non-profits for Social Impact
Melbourne social enterprise Who Gives A Crap sold nearly 3 million rolls of toilet paper in 2014/15 and gave half the proceeds to WaterAid Australia, but co-founder Simon Griffiths says the donation would have been less had the startup adopted a non-profit model when it launched two years ago.
